Stereotactic body radiotherapy plus pembrolizumab and trametinib for pancreatic cancer

被引：11
|
作者：
Zhu, Xiaofei [1 ]
Cao, Yangsen [1 ]
Zhang, Huojun [1 ]
机构：
[1] Second Mil Med Univ, Changhai Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China
来源：
LANCET ONCOLOGY | 2020年 / 22卷 / 10期
关键词：
RESECTION;
D O I：
10.4143/crt.2020.928
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E424 / E424
页数：1
相关论文
共 50 条
  • [31] Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions
    Myrehaug, Sten
    Sahgal, Arjun
    Russo, Suzanne M.
    Lo, Simon S.
    Rosati, Lauren M.
    Mayr, Nina A.
    Lock, Michael
    Small, William, Jr.
    Dorth, Jennifer A.
    Ellis, Rodney J.
    Teh, Bin S.
    Herman, Joseph M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (05) : 523 - 530
  • [32] Stereotactic body radiotherapy in the treatment of Pancreatic Adenocarcinoma
    Gawish, Ahmed
    Brunner, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 89 - 89
  • [33] Stereotactic body radiotherapy in the treatment of Pancreatic carcinoma
    Gawish, A.
    Walke, M.
    El-Arayed, S.
    Brunner, T. B.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1097 - S1097
  • [34] Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy
    Panje, Cedric
    Andratschke, Nikolaus
    Brunner, Thomas B.
    Niyazi, Maximilian
    Guckenberger, Matthias
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (12) : 875 - 885
  • [35] Clinical outcomes following stereotactic ablative body radiotherapy to inoperable pancreatic cancer
    Duong, J.
    Harrison, M.
    Tsang, Y.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S2087 - S2088
  • [36] A DOSIMETRIC MODEL OF DUODENAL TOXICITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR PANCREATIC CANCER
    Murphy, James D.
    Christman-Skieller, Claudia
    Kim, Jeff
    Dieterich, Sonja
    Chang, Daniel T.
    Koong, Albert C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (05): : 1420 - 1426
  • [37] Clinical experience of using stereotactic ablative body radiotherapy on inoperable pancreatic cancer
    Duong, J.
    Tsang, Y. M.
    Harrison, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S1066 - S1067
  • [38] Stereotactic Body Radiotherapy in isolated recurrence of pancreatic cancer after radical surgery
    Massaro, M.
    Comito, T.
    Teriaca, M. A.
    Franzese, C.
    Di Cristina, L.
    Marzo, A. M.
    Reggiori, G.
    Gallo, P.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1102 - S1103
  • [39] Adaptive MR guided stereotactic body radiotherapy for locally advanced pancreatic cancer
    Ejlsmark, M.
    Schytte, T.
    Hansen, O.
    Bernchou, U.
    Bertelsen, A.
    Detlefsen, S.
    Mortensen, M. B.
    Hansen, C. R.
    Jensen, H.
    Bahij, R.
    Weber, B.
    Pfeiffer, P.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S366 - S367
  • [40] TWO SEQUENTIAL PILOT STUDIES: STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC BREAST CANCER (BOSTON) AND STEREOTACTIC ABLATIVE RADIOTHERAPY plus PEMBROLIZUMAB FOR OLIGOMETASTATIC BREAST CANCER (BOSTON II)
    David, Steven
    Siva, Shankar
    Bressel, Mathias
    Savas, Peter
    Foroudi, Farshad
    Loi, Sherene
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 167 - 167
12345